Sodium-dependent vitamin C transporter SVCT2: Expression and function in bone marrow stromal cells and in osteogenesis

Sadanand Fulzele, Paresh Chothe, Rajnikumar Sangani, Norman Chutkan, Mark Hamrick, Maryka Bhattacharyya, Puttur D. Prasad, Ibrahim Zakhary, Matthew Bowser, Carlos Isales, Vadivel Ganapathy

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Ascorbic acid (Vitamin C) has a critical role in bone formation and osteoblast differentiation, but very little is known about the molecular mechanisms of ascorbic acid entry into bone marrow stromal cells (BMSCs). To address this gap in knowledge, we investigated the identity of the transport system that is responsible for the uptake of ascorbic acid into bone marrow stromal cells (BMSCs). First, we examined the expression of the two known isoforms of the sodium-coupled ascorbic acid transporter, namely SVCT1 and SVCT2, in BMSCs (Lin-ve Sca1+ve) and bone at the mRNA level. Only SVCT2 mRNA was detected in BMSCs and bone. Uptake of ascorbic acid in BMSCs was Na+-dependent and saturable. In order to define the role of SVCT2 in BMSC differentiation into osteoblasts, BMSCs were stimulated with osteogenic media for different time intervals, and the activity of SVCT2 was monitored by ascorbic acid uptake. SVCT2 expression was up-regulated during the osteogenic differentiation of BMSCs; the expression was maximal at the earliest phase of differentiation. Subsequently, osteogenesis was inhibited in BMSCs upon knock-down of SVCT2 by lentivirus shRNA. We also found that the expression of the SVCT2 could be negatively or positively modulated by the presence of oxidant (Sin-1) or antioxidant (Ascorbic acid) compounds, respectively, in BMSCs. Furthermore, we found that this transporter is also regulated with age in mouse bone. These data show that SVCT2 plays a vital role in the osteogenic differentiation of BMSCs and that its expression is altered under conditions associated with redox reaction. Our findings could be relevant to bone tissue engineering and bone related diseases such as osteoporosis in which oxidative stress and aging plays important role.

Original languageEnglish (US)
Pages (from-to)36-47
Number of pages12
JournalStem Cell Research
Volume10
Issue number1
DOIs
StatePublished - Jan 1 2013

Fingerprint

Sodium-Coupled Vitamin C Transporters
Mesenchymal Stromal Cells
Osteogenesis
Ascorbic Acid
Bone and Bones
Osteoblasts
Lentivirus
Messenger RNA
Bone Diseases
Tissue Engineering

ASJC Scopus subject areas

  • Developmental Biology
  • Cell Biology

Cite this

Sodium-dependent vitamin C transporter SVCT2 : Expression and function in bone marrow stromal cells and in osteogenesis. / Fulzele, Sadanand; Chothe, Paresh; Sangani, Rajnikumar; Chutkan, Norman; Hamrick, Mark; Bhattacharyya, Maryka; Prasad, Puttur D.; Zakhary, Ibrahim; Bowser, Matthew; Isales, Carlos; Ganapathy, Vadivel.

In: Stem Cell Research, Vol. 10, No. 1, 01.01.2013, p. 36-47.

Research output: Contribution to journalArticle

Fulzele, Sadanand ; Chothe, Paresh ; Sangani, Rajnikumar ; Chutkan, Norman ; Hamrick, Mark ; Bhattacharyya, Maryka ; Prasad, Puttur D. ; Zakhary, Ibrahim ; Bowser, Matthew ; Isales, Carlos ; Ganapathy, Vadivel. / Sodium-dependent vitamin C transporter SVCT2 : Expression and function in bone marrow stromal cells and in osteogenesis. In: Stem Cell Research. 2013 ; Vol. 10, No. 1. pp. 36-47.
@article{39c68eac65634cde9b550b8ae9f1632b,
title = "Sodium-dependent vitamin C transporter SVCT2: Expression and function in bone marrow stromal cells and in osteogenesis",
abstract = "Ascorbic acid (Vitamin C) has a critical role in bone formation and osteoblast differentiation, but very little is known about the molecular mechanisms of ascorbic acid entry into bone marrow stromal cells (BMSCs). To address this gap in knowledge, we investigated the identity of the transport system that is responsible for the uptake of ascorbic acid into bone marrow stromal cells (BMSCs). First, we examined the expression of the two known isoforms of the sodium-coupled ascorbic acid transporter, namely SVCT1 and SVCT2, in BMSCs (Lin-ve Sca1+ve) and bone at the mRNA level. Only SVCT2 mRNA was detected in BMSCs and bone. Uptake of ascorbic acid in BMSCs was Na+-dependent and saturable. In order to define the role of SVCT2 in BMSC differentiation into osteoblasts, BMSCs were stimulated with osteogenic media for different time intervals, and the activity of SVCT2 was monitored by ascorbic acid uptake. SVCT2 expression was up-regulated during the osteogenic differentiation of BMSCs; the expression was maximal at the earliest phase of differentiation. Subsequently, osteogenesis was inhibited in BMSCs upon knock-down of SVCT2 by lentivirus shRNA. We also found that the expression of the SVCT2 could be negatively or positively modulated by the presence of oxidant (Sin-1) or antioxidant (Ascorbic acid) compounds, respectively, in BMSCs. Furthermore, we found that this transporter is also regulated with age in mouse bone. These data show that SVCT2 plays a vital role in the osteogenic differentiation of BMSCs and that its expression is altered under conditions associated with redox reaction. Our findings could be relevant to bone tissue engineering and bone related diseases such as osteoporosis in which oxidative stress and aging plays important role.",
author = "Sadanand Fulzele and Paresh Chothe and Rajnikumar Sangani and Norman Chutkan and Mark Hamrick and Maryka Bhattacharyya and Prasad, {Puttur D.} and Ibrahim Zakhary and Matthew Bowser and Carlos Isales and Vadivel Ganapathy",
year = "2013",
month = "1",
day = "1",
doi = "10.1016/j.scr.2012.08.004",
language = "English (US)",
volume = "10",
pages = "36--47",
journal = "Stem Cell Research",
issn = "1873-5061",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Sodium-dependent vitamin C transporter SVCT2

T2 - Expression and function in bone marrow stromal cells and in osteogenesis

AU - Fulzele, Sadanand

AU - Chothe, Paresh

AU - Sangani, Rajnikumar

AU - Chutkan, Norman

AU - Hamrick, Mark

AU - Bhattacharyya, Maryka

AU - Prasad, Puttur D.

AU - Zakhary, Ibrahim

AU - Bowser, Matthew

AU - Isales, Carlos

AU - Ganapathy, Vadivel

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Ascorbic acid (Vitamin C) has a critical role in bone formation and osteoblast differentiation, but very little is known about the molecular mechanisms of ascorbic acid entry into bone marrow stromal cells (BMSCs). To address this gap in knowledge, we investigated the identity of the transport system that is responsible for the uptake of ascorbic acid into bone marrow stromal cells (BMSCs). First, we examined the expression of the two known isoforms of the sodium-coupled ascorbic acid transporter, namely SVCT1 and SVCT2, in BMSCs (Lin-ve Sca1+ve) and bone at the mRNA level. Only SVCT2 mRNA was detected in BMSCs and bone. Uptake of ascorbic acid in BMSCs was Na+-dependent and saturable. In order to define the role of SVCT2 in BMSC differentiation into osteoblasts, BMSCs were stimulated with osteogenic media for different time intervals, and the activity of SVCT2 was monitored by ascorbic acid uptake. SVCT2 expression was up-regulated during the osteogenic differentiation of BMSCs; the expression was maximal at the earliest phase of differentiation. Subsequently, osteogenesis was inhibited in BMSCs upon knock-down of SVCT2 by lentivirus shRNA. We also found that the expression of the SVCT2 could be negatively or positively modulated by the presence of oxidant (Sin-1) or antioxidant (Ascorbic acid) compounds, respectively, in BMSCs. Furthermore, we found that this transporter is also regulated with age in mouse bone. These data show that SVCT2 plays a vital role in the osteogenic differentiation of BMSCs and that its expression is altered under conditions associated with redox reaction. Our findings could be relevant to bone tissue engineering and bone related diseases such as osteoporosis in which oxidative stress and aging plays important role.

AB - Ascorbic acid (Vitamin C) has a critical role in bone formation and osteoblast differentiation, but very little is known about the molecular mechanisms of ascorbic acid entry into bone marrow stromal cells (BMSCs). To address this gap in knowledge, we investigated the identity of the transport system that is responsible for the uptake of ascorbic acid into bone marrow stromal cells (BMSCs). First, we examined the expression of the two known isoforms of the sodium-coupled ascorbic acid transporter, namely SVCT1 and SVCT2, in BMSCs (Lin-ve Sca1+ve) and bone at the mRNA level. Only SVCT2 mRNA was detected in BMSCs and bone. Uptake of ascorbic acid in BMSCs was Na+-dependent and saturable. In order to define the role of SVCT2 in BMSC differentiation into osteoblasts, BMSCs were stimulated with osteogenic media for different time intervals, and the activity of SVCT2 was monitored by ascorbic acid uptake. SVCT2 expression was up-regulated during the osteogenic differentiation of BMSCs; the expression was maximal at the earliest phase of differentiation. Subsequently, osteogenesis was inhibited in BMSCs upon knock-down of SVCT2 by lentivirus shRNA. We also found that the expression of the SVCT2 could be negatively or positively modulated by the presence of oxidant (Sin-1) or antioxidant (Ascorbic acid) compounds, respectively, in BMSCs. Furthermore, we found that this transporter is also regulated with age in mouse bone. These data show that SVCT2 plays a vital role in the osteogenic differentiation of BMSCs and that its expression is altered under conditions associated with redox reaction. Our findings could be relevant to bone tissue engineering and bone related diseases such as osteoporosis in which oxidative stress and aging plays important role.

UR - http://www.scopus.com/inward/record.url?scp=84867610391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867610391&partnerID=8YFLogxK

U2 - 10.1016/j.scr.2012.08.004

DO - 10.1016/j.scr.2012.08.004

M3 - Article

C2 - 23089627

AN - SCOPUS:84867610391

VL - 10

SP - 36

EP - 47

JO - Stem Cell Research

JF - Stem Cell Research

SN - 1873-5061

IS - 1

ER -